09.12.2009
- Dutch biotech firm Crucell reported a surprise Q1 profit, its third in a row, on strong sales of paediatric vaccines and the company, widely viewed as a takeover target, reiterated...
09.12.2009
- Huntsman posted a wider-than-expected quarterly loss, hurt by decreased demand in all of its businesses. Net loss for the Q1 was $290 million compared with net income of $7 million...
09.12.2009
- Hexion specialty chemicals announced Q1 revenues of $914 million and says operating income was $12 million in Q1. The company also announced that it had reduced net debt in Q1 by...
09.12.2009
- In the first three months of 2009 Cognis saw its sales volumes decline by about 18 % in comparison to the Q1 of 2008. Compared with the Q4 of 2008 volumes actually increased by 5 %...
09.12.2009
- Solvay posted a 53 % fall in recurring Q1 operating profit, beating estimates, but said full-year operating profit would be below 2008. Recurring earnings before interest and tax...
09.12.2009
- Arkema announced Q1 sales of €1.092 billion. Q1 Ebitda fell by 64 % to €57 million. Visibility remains very low, and the company cannot see any noticeable improvement in the...
09.12.2009
- Novartis is buying the injectable generic cancer drugs business of Austria's Ebewe Pharma and may pursue other similar deals as it fleshes out a planned diversification away from...
09.12.2009
- Just three months after embarking on an exclusive strategic alliance to serve the $2-billion-plus worldwide foam-control market, Clariant is acquiring Dalton, Ga.-based XL...
09.12.2009
- Pfizer announced it is expanding its generics portfolio through innovative licensing deals, increasing access to medicines for billions worldwide. The company says it has entered...
09.12.2009
- Dow Chemical said it is divesting its calcium chloride business and its interests in TRN refinery. The company says it signed two separate sale agreements totalling in excess of...
